"Methods And Compositions For Treating Cancer" in Patent Application Approval Process (USPTO 20240327519).

The patent application titled "Methods And Compositions For Treating Cancer" discusses the development of a bispecific antibody targeting PD-1 and LAG3 for the treatment of various cancers, including melanoma and liver cancer. The method involves administering the bispecific antibody at a fixed dose of 600 mg every three weeks. The application highlights the urgent need for novel therapeutic approaches in cancer treatment due to the increasing incidence and significant global public health impact of cancers like melanoma and liver cancer. [Extracted from the article]